V
Valo Health
Cloud computing as well as longitudinal and human data to create an entirely new drug discovery and development process
Knowledge graph
Open roles
Valo Health in the Boston ecosystem
The Valo Health office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Flagship Pioneering- HCHercules Capital
- PIPSP Investments
Series B and later5 investors entered at this stage
- MCMirae Asset Capital
- KTKoch Disruptive Technologies
- AIAtinum Investment
- INInvus
- HIHBM Healthcare Investments
Ownership
Estimated cap table from Dealroom's shareholder data — share of equity by holder. Stakes as last recorded by Dealroom (2026). Percentages are indicative.
Some investors are hidden on this public profile. See the full cap table on Dealroom →
Source: Dealroom Talent Intelligence.
Patents
56 active patent families included in this estimate.
A patent family groups patent filings for the same invention. Source: Dealroom · PatSnap.
See Valo Health on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.
Valo and Montai merge to build human-evidence drug discovery platform
